{
    "Trade/Device Name(s)": [
        "Element\u2122 Lite Blood Glucose Monitoring System",
        "Element\u2122M Lite Blood Glucose Monitoring System",
        "Element\u2122M Lite Meter",
        "Element\u2122M Lite Test Strips",
        "Element\u2122M Lite Control Solutions"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K133045",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113670"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "September 24, 2013",
    "Summary Letter Received Date": "September 27, 2013",
    "Submission Date": "03/13/2014",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (specified) analyte controls"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Element\u2122M Lite Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Element\u2122M Lite Blood Glucose Monitoring System using electrochemical detection for self-monitoring of blood glucose",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various sites for self-testing by people with diabetes at home as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}